CFDE Data Portal | Search BMS1P4-AGAP5

	Label	Description
	BMS1P4-AGAP5 Gene (Entity type)	ENSG00000242288 - BMS1P4-AGAP5 readthrough
	GSE111247 temozolomide LN-308 2 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207499 sphingosine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE156761 dopamine neuron 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE224105 GSE224108 zearalenone 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

BMS1P4-AGAP5

ENSG00000242288 - BMS1P4-AGAP5 readthrough

GSE111247 temozolomide LN-308 2 v 13 human up

A Gene Set from LINCS

GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human up

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 3 v 6 human up

A Gene Set from LINCS

GSE207499 sphingosine 1 v 0 human up

A Gene Set from LINCS

GSE176008 pyridoxine 7 v 3 human dn

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 5 human up

A Gene Set from LINCS

GSE156761 dopamine neuron 0 v 3 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE224105 GSE224108 zearalenone 3 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.